Heart - Stocks of the Day

Stocks of the Day

Sign In / Sign Up

Latest News
Stock Screener
AI Signals
News Archive
Membership
About
- About
- FAQ
- Blog
- Contact Us

Home
Latest News
Stock Screener
AI Signals
News Archive
Membership
About
- About
- FAQ
- Blog
- Contact Us

Register Free
Sign in

Search mobile

Topic :

Heart

JNJ, NYSE

#AI #Heart

AtlantiCare First in Northeast to Deploy Optellum AI Alongside Robotics for Early Lung Cancer Diagnosis and Treatment

February 23, 2023
03:05

EST

AtlantiCare joined leading healthcare systems worldwide by becoming the first system in the northeastern U.S. to use the Optellum Virtual Nodule Clinic. EGG HARBOR TOWNSHIP, N.J., Feb. 23, 2023 /PRNewswire/ — AtlantiCare is the first healthcare system in the northeastern U.S. to use Optellum’s Virtual Nodule Clinic. Located in New

No Comments

NASDAQ, TMDX

#Featured #Financial Data #Heart #Trending News

TransMedics Reports Fourth Quarter and Full Year 2022 Financial Results

February 22, 2023
16:09

EST

ANDOVER, Mass., Feb. 22, 2023 /PRNewswire/ – TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter and year ended December 31, 2022. Recent Highlights Total revenue

No Comments

FDMT, NASDAQ

#Heart #New Clinical Trial Data #Phase 1/2 #Trending News

4D Molecular Therapeutics Presents Interim Data from 4D-310 INGLAXA Phase 1/2 Clinical Trials & Development Plans for Fabry Disease Cardiomyopathy at WORLDSymposium™

February 22, 2023
16:05

EST

All three patients with 12 months of follow-up demonstrated improvement in multiple FDA-recommended cardiac endpoints at relatively low dose of 1E13 vg/kg Cardiac biopsy demonstrated selective and widespread transgene expression within ~50% of cardiomyocytes Engaging with FDA to lift clinical hold and resume enrollment with updated exclusion criteria and

No Comments

NASDAQ, TMDX

#Heart #Investor Conference #Trending News

TransMedics to Present at Upcoming March Investor Conferences

February 21, 2023
16:05

EST

ANDOVER, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in two upcoming investor conferences. TransMedics management is scheduled

No Comments

ETNB, NASDAQ

#Heart #Phase 2 #Upcoming Clinical Trial Presentation

89bio to Present Additional Pegozafermin Data in Severe Hypertriglyceridemia from Phase 2 ENTRIGUE Study at American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology

February 21, 2023
08:00

EST

SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced additional pegozafermin data from the Phase 2 ENTRIGUE study in severe hypertriglyceridemia (SHTG) will

No Comments

NVST, NYSE

#Heart #New Partnership

Envista Smile Project donates more than $650,000 in charitable giving in 2022

February 21, 2023
07:00

EST

BREA, Calif., Feb. 21, 2023 /PRNewswire/ — As part of its commitment to expanding and improving access to oral health for those in need, Envista Holdings Corporation (NYSE: NVST) (“Envista”) announced today that the Envista Smile Project (Smile Project), donated more than $650,000 in 2022. Last year, the non-profit organization:

No Comments

LXRX, NASDAQ

#Heart #Trending News #Upcoming Clinical Trial Presentation

New Analyses of Sotagliflozin to Be Presented at the American College of Cardiology’s 72nd Annual Scientific Session Together With World Heart Federation’s World Congress of Cardiology

February 20, 2023
08:00

EST

THE WOODLANDS, Texas, Feb. 20, 2023 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced the upcoming presentation of new analyses of results from the SOLOIST-WHF Phase 3 outcomes study of its investigational sotagliflozin product at the American College of Cardiology’s 72nd Annual Scientific Session Together With World

No Comments

MDT, NYSE

#Heart #Third-Party Article

MDT Stock: 0.71% Increase Explanation

February 20, 2023
01:52

EST

The stock price of Medtronic PLC (NYSE: MDT) increased by 0.71% in the most recent trading session. This is why. The stock price of Medtronic PLC (NYSE: MDT) increased by 0.71% in the most recent trading session. Why: Medtronic has received CE (Conformité Européenne) Mark for the Aurora EV-ICD

No Comments

MDT, NYSE

#Heart #Trending News

Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms

February 17, 2023
08:30

EST

EV-ICD defibrillation lead placed outside of heart and veins, preserving vasculature DUBLIN, Feb. 17, 2023 /PRNewswire/ — Medtronic plc (NYSE:MDT) has received CE (Conformité Européenne) Mark for the Aurora EV-ICD™ MRI SureScan™ (Extravascular Implantable Cardioverter-Defibrillator) and Epsila EV™ MRI SureScan™ defibrillation lead to treat dangerously fast heart rhythms that can

No Comments

CNVCF, OTC

#Heart

BioHarvest Sciences Collaborating with Yo Murphy and NFL Prospects to Build Awareness of Blood Flow Importance

February 16, 2023
09:15

EST

NFL wide receiver-turned-trainer Yo Murphy educates players on the importance of using science-based solutions like VINIA® to optimize their heart health and general wellness during and after sports career VINIA® selected to optimize players’ blood flow and delivery of oxygen to their body via its unique ability to increase

No Comments

< Page1 Page2 Page3 … Page51 >

Trending News

ObsEva Announces Strategic Reorganization to Consolidate Operations in Switzerland

02/24/2023

Tactile Systems Technology, Inc. Announces Pricing of $32.5 Million Public Offering of Common Stock

02/23/2023

Gatos Silver Announces 2023 Production and Cost Guidance

02/23/2023

Columbia Banking System Set to Join S&P MidCap 400; Verra Mobility to Join S&P SmallCap 600

02/23/2023

MasTec Announces Fourth Quarter and Annual 2022 Financial Results

02/23/2023

Most read news

DelphX Announces Non-Brokered Unit Financing

02/22/2023

IRM Stock: 4.23% Increase Explanation

02/24/2023

Kontrol Technologies Completes Equity Private Placement of $5 Million CAD

02/22/2023

© 2022 stocksoftheday.

Stocks of the Day does not provide investment advice. All rights reserved.

Tools

Predictions
Stock Screener
News Archive
News Feed
News Tags
Tickers
Trending Tickers
News Sentiments
Holidays & Trading Hours

Learn

FAQ
Guides
Infographics
Affiliate Program FAQ

Account

Sign In
Register
Email Preferences
Membership Option

Company

About
Contact Us
Careers
Blog
Privacy Policy
Terms of Use
Sitemap

Partnerships

Affiliate Program
Partnerships

Create account

Let the news trading begin!

Continue with Google

Continue with Facebook

Continue with Reddit

Continue with Discord

or

First Name

Last Name

Email

Password

I agree with the Terms of Use and Privacy Policy.

Already have an account?

Sign In

Let the news trading begin!

Continue with Google

Continue with Facebook

Continue with Reddit

Continue with Discord

or

Email

Password

Remember me

Lost your password?

Not registered yet?

Create a free account

Sign In

Let the news trading begin!

Continue with Google

Continue with Facebook

Continue with Reddit

Continue with Discord

or

Email

Password

Remember me

Lost your password?

Not registered yet?

Create a free account